Aprea Therapeutics, Inc. (APRE)
0.865
+0.06
(+8.12%)
USD |
NASDAQ |
Sep 01, 15:48
Aprea Therapeutics Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.0281M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0298M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0338M |
| December 31, 2020 | 0.0788M |
| September 30, 2020 | 0.1328M |
| June 30, 2020 | 0.1859M |
| March 31, 2020 | 0.4661M |
| December 31, 2019 | 0.3026M |
| September 30, 2019 | 0.3584M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Zymeworks, Inc. | 265.33M |
| Rhythm Pharmaceuticals, Inc. | 109.08M |
| Onconetix, Inc. | 0.0123M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |